IGFBP1 and cardiovascular disorder: In conclusion, this study suggests that the majority of subjects with low fasting IGFBP-1 and adiponectin levels benefit from bariatric surgery with improved insulin sensitivity and glucose tolerance as well as reduced risk factors for cardiovascular disease and future abnormal glucose tolerance.